{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:44:49Z","timestamp":1777484689601,"version":"3.51.4"},"reference-count":34,"publisher":"Medknow","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T00:00:00Z","timestamp":1435881600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian Pacific Journal of Tropical Medicine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.apjtm.2015.06.008","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T04:52:53Z","timestamp":1436417573000},"page":"513-519","source":"Crossref","is-referenced-by-count":14,"title":["Immunogenicity and efficacy of recombinant 78\u00a0kDa antigen of Leishmania donovani formulated in various adjuvants against murine visceral leishmaniasis"],"prefix":"10.4103","volume":"8","author":[{"given":"Rajeev","family":"Nagill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhbir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"10.1016\/j.apjtm.2015.06.008_bib1","first-page":"1","article-title":"Leishmania vaccines updates","volume":"5","author":"Basyoni","year":"2012","journal-title":"PUJ"},{"key":"10.1016\/j.apjtm.2015.06.008_bib2","series-title":"WHO technical report series","first-page":"1","article-title":"Control of the leishmaniases","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.apjtm.2015.06.008_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1371\/journal.pntd.0000313","article-title":"Complexities of assessing the disease burden attributed to leishmaniasis","volume":"2","author":"Bern","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.apjtm.2015.06.008_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.apjtm.2015.06.008_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: newer developments","volume":"4","author":"Mohapatra","year":"2014","journal-title":"Trop Parasitol"},{"key":"10.1016\/j.apjtm.2015.06.008_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1473-3099(05)70085-2","article-title":"Recombinant DNA-derived Leishmania proteins: from the laboratory to the field","volume":"5","author":"Kubar","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.apjtm.2015.06.008_bib7","first-page":"1","article-title":"Searching genes encoding Leishmania antigens for diagnosis and protection","volume":"2009","author":"Soto","year":"2009","journal-title":"Sch Res Exch"},{"key":"10.1016\/j.apjtm.2015.06.008_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fimmu.2012.00099","article-title":"Vaccine development against Leishmania donovani","volume":"3","author":"Das","year":"2012","journal-title":"Front Immunol"},{"issue":"17\u201318","key":"10.1016\/j.apjtm.2015.06.008_bib9","first-page":"2170","article-title":"DNA vaccines induce partial protection against Leishmania mexicana","volume":"21","author":"Dumonteil","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.apjtm.2015.06.008_bib10","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36 (LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.apjtm.2015.06.008_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vaccine.2008.10.013","article-title":"DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania major antigens confers full protection in BALB\/c mice","volume":"27","author":"Ahmed","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.apjtm.2015.06.008_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.vaccine.2007.11.044","article-title":"Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis","volume":"26","author":"Ferreira","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.apjtm.2015.06.008_bib13","first-page":"181690","article-title":"BALB\/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge","volume":"2010","author":"Ramirez","year":"2010","journal-title":"J\u00a0Biomed Biotechnol"},{"issue":"29\u201330","key":"10.1016\/j.apjtm.2015.06.008_bib14","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2006.04.062","article-title":"Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB\/c mice","volume":"24","author":"Jaafari","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.apjtm.2015.06.008_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/pim.12071","article-title":"To investigate the therapeutic potential of immunochemotherapy with cisplatin+78kDa+MPL-A against Leishmania donovani in BALB\/c mice","volume":"36","author":"Joshi","year":"2014","journal-title":"Parasit Immunol"},{"key":"10.1016\/j.apjtm.2015.06.008_bib16","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.apjtm.2015.06.008_bib17","first-page":"119","article-title":"Regulation of Leishmania populations within host I. the variable course of Leishmania donovani infections in mice","volume":"30","author":"Bradley","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.apjtm.2015.06.008_bib18","first-page":"1","article-title":"Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB\/c mice","author":"Joshi","year":"2014","journal-title":"Parasitol"},{"key":"10.1016\/j.apjtm.2015.06.008_bib19","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2010.01.015","article-title":"Enhanced efficacy and immunogenicity of 78 kDa antigen formulated in various adjuvants against murine visceral leishmaniasis","volume":"28","author":"Nagill","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.apjtm.2015.06.008_bib20","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.intimp.2011.05.008","article-title":"Vaccine candidates for leishmaniasis: a review","volume":"11","author":"Nagill","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.apjtm.2015.06.008_bib21","doi-asserted-by":"crossref","first-page":"e1429","DOI":"10.1371\/journal.pntd.0001429","article-title":"Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: hgh immunogenicity and protection","volume":"5","author":"Mazumder","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.apjtm.2015.06.008_bib22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1128\/CVI.00060-07","article-title":"Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World","volume":"14","author":"Salay","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.apjtm.2015.06.008_bib23","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","article-title":"LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile","volume":"161","author":"Skeiky","year":"1998","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.apjtm.2015.06.008_bib24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1517\/14712598.4.7.1129","article-title":"Taking a toll on human disease: toll-like receptor 4 agonists as vaccine adjuvants and mono therapeutic agents","volume":"4","author":"Baldridge","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"9\u201310","key":"10.1016\/j.apjtm.2015.06.008_bib25","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.vaccine.2003.09.030","article-title":"A\u00a0mixed Th1\/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB\/c mice","volume":"22","author":"Mazumdar","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.apjtm.2015.06.008_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.iy.12.040194.003223","article-title":"Acquisition of lymphokine-producing phenotype by CD4+ T cells","volume":"12","author":"Seder","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.apjtm.2015.06.008_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1574-695X.2007.00311.x","article-title":"Immune response to Leishmania: paradox rather than paradigm","volume":"51","author":"Tripathi","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"10.1016\/j.apjtm.2015.06.008_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferongamma or interleukin duringthe resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"Heinzel","year":"1989","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.apjtm.2015.06.008_bib29","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.4049\/jimmunol.143.12.4244","article-title":"Experimental visceral leishmaniasis: role of endogenous IFN-\u03b3 in host defense and tissue granulomatous response","volume":"143","author":"Squires","year":"1989","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.apjtm.2015.06.008_bib30","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.apjtm.2015.06.008_bib31","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI113969","article-title":"Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated","volume":"83","author":"Carvalho","year":"1989","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.apjtm.2015.06.008_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin 10 production correlates with pathology in human Leishmania donovani infections","volume":"92","author":"Ghalib","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.apjtm.2015.06.008_bib33","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.152.12.5949","article-title":"Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis","volume":"152","author":"Carvalho","year":"1994","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.apjtm.2015.06.008_bib34","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur J Immunol"}],"container-title":["Asian Pacific Journal of Tropical Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1995764515000656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1995764515000656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T03:53:03Z","timestamp":1691812383000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995764515000656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1995764515000656"],"URL":"https:\/\/doi.org\/10.1016\/j.apjtm.2015.06.008","relation":{},"ISSN":["1995-7645"],"issn-type":[{"value":"1995-7645","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}